rts logo

Positives for MaxCyte Inc (MXCT) as stock gains in recent trading

MaxCyte Inc (NASDAQ: MXCT) is -8.09% lower on its value in year-to-date trading and has touched a low of $2.45 and a high of $5.55 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The MXCT stock was last observed hovering at around $4.31 in the last trading session, with the day’s gains setting it 0.01%.

Currently trading at $4.32, the stock is 2.69% and 0.75% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.44 million and changing 0.23% at the moment leaves the stock -3.50% off its SMA200. MXCT registered 16.13% gain for a year compared to 6-month loss of -8.28%.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The stock witnessed a -5.47% gain in the last 1 month and extending the period to 3 months gives it a -3.57%, and is -0.69% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.70% over the week and 6.17% over the month.

MaxCyte Inc (MXCT) has around 143 employees, a market worth around $453.99M and $45.44M in sales. Profit margin for the company is -77.97%. Distance from 52-week low is 76.33% and -22.09% from its 52-week high. The company has generated returns on investments over the last 12 months (-14.83%).

with sales reaching $7.37M over the same period.The EPS is expected to shrink by -14.67% this year, but quarterly earnings will post -10.60% year-over-year.

MaxCyte Inc (MXCT) Top Institutional Holders

185.0 institutions hold shares in MaxCyte Inc (MXCT), with institutional investors hold 76.65% of the company’s shares. The shares outstanding are 103.96M, and float is at 96.82M with Short Float at 3.95%. Institutions hold 75.54% of the Float.

The top institutional shareholder in the company is BLACKROCK INC. with over 8.14 million shares valued at $31.92 million. The investor’s holdings represent 7.8224% of the MXCT Shares outstanding. As of 2024-06-30, the second largest holder is CADIAN CAPITAL MANAGEMENT, LP with 7.62 million shares valued at $$29.88 million to account for 7.3234 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 5.65 million shares representing 5.4233% and valued at over $22.13 million, while MILLENNIUM MANAGEMENT LLC holds 4.9745 of the shares totaling 5.18 million with a market value of $20.3 million.

MaxCyte Inc (MXCT) Insider Activity

The most recent transaction is an insider sale by Johnston John Joseph,the company’sDirector. SEC filings show that Johnston John Joseph sold 3,000 shares of the company’s common stock on Aug 26 ’24 at a price of $4.28 per share for a total of $12840.0. Following the sale, the insider now owns 0.14 million shares.

MaxCyte Inc disclosed in a document filed with the SEC on Aug 02 ’24 that Ross Thomas M. (EVP, GLOBAL SALES) sold a total of 17,857 shares of the company’s common stock. The trade occurred on Aug 02 ’24 and was made at $4.36 per share for $77874.0. Following the transaction, the insider now directly holds 25000.0 shares of the MXCT stock.

Still, SEC filings show that on Aug 01 ’24, Ross Thomas M. (EVP, GLOBAL SALES) disposed off 15,476 shares at an average price of $4.54 for $70261.0. The insider now directly holds 25,000 shares of MaxCyte Inc (MXCT).

Related Posts